. . "Gene expression profiling in follicular lymphoma and its implication for clinical practice" . . . "V\u00E1\u0161ov\u00E1, Ingrid" . "10"^^ . . . "\u0160up\u00EDkov\u00E1, Jana" . . . "K\u0159en, Leo\u0161" . "Tich\u00FD, Boris" . . "RIV/65269705:_____/11:#0001275!RIV12-MZ0-65269705" . "\u0160\u00E1lek, David" . . "Jan\u00EDkov\u00E1, Andrea" . "Mayer, Ji\u0159\u00ED" . . . "52" . . "RIV/65269705:_____/11:#0001275" . "Leukemia & Lymphoma" . "P(FR-TI2/254), P(NS10439), Z(MSM0021622430)" . . . "200880" . "follicular lymphoma"@en . "1042-8194" . "Gene expression profiling in follicular lymphoma and its implication for clinical practice"@en . "1" . . "Follicular lymphoma (FL) is characterized by an indolent and relapsing course. Recently, the clinical outcome of FL has been distinguished by immune microenvironment-associated gene signatures. In our study, gene expression profiling (GEP) was performed in 31 non-selected patients with follicular lymphoma (FL), 12 of whom were in relapse and the remaining 19 newly diagnosed. A custom oligonucleotide microarray was used which contained probes for about 3500 genes, including those that had been previously published as demonstrating significant prognostic value. An unsupervised approach was not able to recognize clinically different FLs. As the previously published prognostically relevant gene signatures could not be properly verified, probably due to microarray platform differences, template matching was therefore used in order to define two gene sets with differential gene expression among our samples."@en . "9"^^ . . . "Posp\u00ED\u0161ilov\u00E1, \u0160\u00E1rka" . "9"^^ . . . . . "000286901600012" . "Gene expression profiling in follicular lymphoma and its implication for clinical practice"@en . "Follicular lymphoma (FL) is characterized by an indolent and relapsing course. Recently, the clinical outcome of FL has been distinguished by immune microenvironment-associated gene signatures. In our study, gene expression profiling (GEP) was performed in 31 non-selected patients with follicular lymphoma (FL), 12 of whom were in relapse and the remaining 19 newly diagnosed. A custom oligonucleotide microarray was used which contained probes for about 3500 genes, including those that had been previously published as demonstrating significant prognostic value. An unsupervised approach was not able to recognize clinically different FLs. As the previously published prognostically relevant gene signatures could not be properly verified, probably due to microarray platform differences, template matching was therefore used in order to define two gene sets with differential gene expression among our samples." . "Gene expression profiling in follicular lymphoma and its implication for clinical practice" . . . "Stano Kozub\u00EDk, Kate\u0159ina" . . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . "10.3109/10428194.2010.531412" . "[DB2B09287880]" .